Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Eva M Verdugo-SivianesInstituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío (HUVR), Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0002-0922-0371
Julia Martínez-PérezInstituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío (HUVR), Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, 41013 Seville, Spain.
Lola E NavasInstituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío (HUVR), Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, 41013 Seville, Spain.
Carmen SáezInstituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío (HUVR), Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0002-8600-0508
Amancio CarneroInstituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío (HUVR), Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0003-4357-3979
Funding
AECC Foundation (Spanish Association of Cancer Research) GC16173720CARRCIBER de Cáncer CB16/12/00275Consejería de Economía, Conocimiento, Empresas y Universidad de la Junta de Andalucía P18-RT-2501Consejería de Salud (Junta de Andalucía) PI-0397-2017Consejería de Transformación Económica, Industria, Conocimiento, y Universidades de la Junta de Andalucía CTEICU/PAIDI 2020, DOC_01655Instituto de Salud Carlos III ISCIII, CM18/00219Ministerio de Ciencia, Innovación y Universidades PID2021-122629OB-I00Ministerio de Ciencia, Innovación y Universidades RED2018-102723-TMinisterio de Ciencia, Innovación y Universidades RTI2018-097455-B-I00
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Efficacy of NAMPT Inhibitors in Pancreatic Cancer After Stratification by MAP17 (PDZK1IP1) Levels. · full record | OpenQuestion